Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 39

1.

Genetic factors affecting HDL levels, structure, metabolism and function.

Sviridov D, Nestel PJ.

Curr Opin Lipidol. 2007 Apr;18(2):157-63. Review.

PMID:
17353664
2.

Genetic determinants of low high-density lipoprotein cholesterol.

Miller M, Zhan M.

Curr Opin Cardiol. 2004 Jul;19(4):380-4. Review.

PMID:
15218400
3.

The value of HDL genetics.

Holleboom AG, Vergeer M, Hovingh GK, Kastelein JJ, Kuivenhoven JA.

Curr Opin Lipidol. 2008 Aug;19(4):385-94. doi: 10.1097/MOL.0b013e328306a043. Review.

PMID:
18607186
4.

Inconsistencies in the genetic prediction of HDL cholesterol versus atherosclerosis.

Carlquist J, Anderson JL.

Curr Opin Cardiol. 2007 Jul;22(4):352-8. Review.

PMID:
17556889
5.

Statins and metabolism of high density lipoprotein.

Sviridov D, Nestel P, Watts G.

Cardiovasc Hematol Agents Med Chem. 2007 Jul;5(3):215-21. Review.

PMID:
17630948
6.
7.

Common variation in genes involved in HDL metabolism influences coronary heart disease risk at the population level.

Brousseau ME.

Rev Endocr Metab Disord. 2004 Dec;5(4):343-9. Review. No abstract available.

PMID:
15486467
8.

Genetic determinants of HDL: monogenic disorders and contributions to variation.

Klos KL, Kullo IJ.

Curr Opin Cardiol. 2007 Jul;22(4):344-51. Review.

PMID:
17556888
10.

Laboratory assessment of HDL heterogeneity and function.

Movva R, Rader DJ.

Clin Chem. 2008 May;54(5):788-800. doi: 10.1373/clinchem.2007.101923. Epub 2008 Mar 28. Review.

11.

HDL elevators and mimetics--emerging therapies for atherosclerosis.

Pal M, Pillarisetti S.

Cardiovasc Hematol Agents Med Chem. 2007 Jan;5(1):55-66. Review.

PMID:
17266548
12.

Determinants of plasma HDL concentrations and reverse cholesterol transport.

Lewis GF.

Curr Opin Cardiol. 2006 Jul;21(4):345-52. Review.

PMID:
16755204
13.

Novel therapies to increase apolipoprotein AI and HDL for the treatment of atherosclerosis.

Wong NC.

Curr Opin Investig Drugs. 2007 Sep;8(9):718-28. Review.

PMID:
17729183
14.

The properties of HDL in genetically engineered mice.

Schultz JR, Rubin EM.

Curr Opin Lipidol. 1994 Apr;5(2):126-37. Review.

PMID:
8044415
15.

High density lipoprotein and coronary heart disease: insights from mutations leading to low high density lipoprotein.

Calabresi L, Franceschini G.

Curr Opin Lipidol. 1997 Aug;8(4):219-24. Review.

PMID:
9253538
16.

[Laboratory assessment of HDL heterogeneity and function].

Movva R, Rader DJ.

Ann Biol Clin (Paris). 2009 Jan-Feb;67(1):7-21. doi: 10.1684/abc.2008.0284. Review. French.

17.

Is raising HDL a futile strategy for atheroprotection?

Joy T, Hegele RA.

Nat Rev Drug Discov. 2008 Feb;7(2):143-55. doi: 10.1038/nrd2489. Review.

PMID:
18239670
18.

[Genetics and dyslipidemias].

Brousseau T, Fruchart JCh.

Arch Mal Coeur Vaiss. 2003 Nov;96(11):1116-20. Review. French.

PMID:
14694789
19.

Effect of ABCA1 mutations on risk for myocardial infarction.

Iatan I, Alrasadi K, Ruel I, Alwaili K, Genest J.

Curr Atheroscler Rep. 2008 Oct;10(5):413-26. Review.

PMID:
18706283
20.

Genetic-epidemiological evidence on genes associated with HDL cholesterol levels: a systematic in-depth review.

Boes E, Coassin S, Kollerits B, Heid IM, Kronenberg F.

Exp Gerontol. 2009 Mar;44(3):136-60. doi: 10.1016/j.exger.2008.11.003. Epub 2008 Nov 17. Review.

Supplemental Content

Support Center